Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus.
Yoshihara T, Kumashiro N, Kanazawa Y, Mita T, Sakurai Y, Kawai J, Abe M, Motojima K, Hara K, Yamazaki Y, Kanazawa A, Miwa S, Sato F, Kanno R, Shimizu T, Sakai K, Uchino H, Watada H, Tanaka Y, Kawamori R, Hirose T. Yoshihara T, et al. Among authors: hirose t. Endocr J. 2006 Feb;53(1):67-72. doi: 10.1507/endocrj.53.67. Endocr J. 2006. PMID: 16543674 Free article. Clinical Trial.
Long-term effect of combination therapy with mitiglinide and once daily insulin glargine in patients who were successfully switched from intensive insulin therapy in short-term study.
Kumashiro N, Yoshihara T, Kanazawa Y, Shimizu T, Watada H, Tanaka Y, Fujitani Y, Kawamori R, Hirose T. Kumashiro N, et al. Among authors: hirose t. Endocr J. 2007 Feb;54(1):163-6. doi: 10.1507/endocrj.k06-153. Epub 2006 Dec 21. Endocr J. 2007. PMID: 17185877 Free article. Clinical Trial.
Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).
Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R, Hirose T. Kanazawa Y, et al. Among authors: hirose t. Endocr J. 2007 Dec;54(6):975-83. doi: 10.1507/endocrj.k07e-035. Epub 2007 Nov 14. Endocr J. 2007. PMID: 18000343 Free article.
Sustained glycaemic control and less nocturnal hypoglycaemia with insulin glargine 300U/mL compared with glargine 100U/mL in Japanese adults with type 1 diabetes (EDITION JP 1 randomised 12-month trial including 6-month extension).
Matsuhisa M, Koyama M, Cheng X, Sumi M, Riddle MC, Bolli GB, Hirose T; EDITION JP 1 study group. Matsuhisa M, et al. Among authors: hirose t. Diabetes Res Clin Pract. 2016 Dec;122:133-140. doi: 10.1016/j.diabres.2016.10.002. Epub 2016 Oct 13. Diabetes Res Clin Pract. 2016. PMID: 27835765 Clinical Trial.
Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12-month comparison by concomitant sulphonylurea and/or glinide use.
Terauchi Y, Riddle MC, Hirose T, Koyama M, Cheng X, Takahashi Y, Bolli GB. Terauchi Y, et al. Among authors: hirose t. Diabetes Obes Metab. 2018 Nov;20(11):2541-2550. doi: 10.1111/dom.13414. Epub 2018 Jul 16. Diabetes Obes Metab. 2018. PMID: 29888454 Free PMC article. Clinical Trial.
Efficacy of intermittent empagliflozin supplementation on dietary self-management and glycaemic control in patients with poorly controlled type 2 diabetes: A 24-week randomized controlled trial.
Yoshikawa F, Kumashiro N, Shigiyama F, Uchino H, Ando Y, Yoshino H, Miyagi M, Ikehara K, Hirose T. Yoshikawa F, et al. Among authors: hirose t. Diabetes Obes Metab. 2019 Feb;21(2):303-311. doi: 10.1111/dom.13524. Epub 2018 Oct 5. Diabetes Obes Metab. 2019. PMID: 30187632 Clinical Trial.
2,686 results